Recent announcements relating to ownership change in this pharma stock prompt us to move this stock from a ‘BUY’ to a ‘HOLD’.
This commodity stock is well placed to play the changing tide in the sector on account of its affordable valuations.
Consolidation and correction have made stocks of affordable housing finance companies attractive and this is our pick in the space.
We are moving an industrial sector stock that we recommended in June 2022, to a HOLD.
We are moving this Prime Stock to a HOLD and this report will explain why.
In part one of this four-part series we talk about examples of wrong entry into stocks with rich valuations and how to avoid them
The second of this four-part series will talk about how you can lose wealth when you entry timing goes wrong in cyclical businesses.
The third of this four-part series talks about how every bull market hides low quality businesses and how you can stay clear of such companies.
Big losses in the stock market: 5 mistakes to avoid – Part 4 (Seeming turnaround stories and no-growth businesses)
In this final part of this four-part series we discuss how many promising turnaround stories never say the light of day in the stock market and also talk about the perils of placing too much faith in dividend earners that show no potential for growth.
This secured, listed and redeemable NCD is issued by India’s 5th largest microfinance company